0001144204-17-013472.txt : 20170405 0001144204-17-013472.hdr.sgml : 20170405 20170308162816 ACCESSION NUMBER: 0001144204-17-013472 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alcentra Capital Corp CENTRAL INDEX KEY: 0001578620 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-922-8240 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Alcentra Capital Corp. DATE OF NAME CHANGE: 20130605 CORRESP 1 filename1.htm

From: Burns, Kristin [mailto:KristinBurns@eversheds-sutherland.us]
Sent: Wednesday, March 08, 2017 12:13 PM
To: minored@sec.gov
Cc: Pangas, Harry S. <HarryPangas@eversheds-sutherland.us>; Park, Adam <AdamPark@eversheds-sutherland.us>
Subject: Alcentra Capital Corporation

Dominic –

Further to our call, the Company has agreed that in any prospectus supplement (whether or not relating to a takedown to sell selling stockholder shares), this sentence in the N-2:

“The selling stockholders will not bear any expenses with respect to the registration of their shares for resale; however, the selling stockholders will be responsible for the brokers’ or underwriters’ discounts and commissions and transfer taxes, if any, relating to the sale or disposition of such shares.”

will be replaced with this disclosure:

“Alcentra NY has agreed to bear all expenses, including legal, accounting, printing and registration fees associated with the registration statement of which this prospectus is a part. We estimate that such expenses will total $50,000. In addition, Alcentra NY has agreed to bear all legal, accounting and printing fees incurred in connection with a prospectus supplement relating to the sale or disposition or such shares held by Alcentra Ltd or BNY Mellon Global Credit Alternatives Fund. To the extent any such prospectus supplement relates to the sale or disposition of shares other than those held by Alcentra Ltd. or BNY Mellon Global Credit Alternatives Fund, Alcentra NY will only bear the portion of such legal, accounting and printing fees that relate to the shares held by Alcentra Ltd. or BNY Mellon Global Credit Alternatives Fund. We estimate that such expenses will not exceed $20,000. The selling stockholders will be responsible for the brokers’ or underwriters’ discounts and commissions and transfer taxes, if any, relating to the sale or disposition of such shares.”

Please let me know if you have any further comments.

Thank you,

Kristin

Kristin Hespos Burns | Associate

Eversheds Sutherland (US) LLP
700 Sixth Street, NW, Suite 700, Washington, DC 20001-3980, US
T: +1.202.383.0918

Email | Biography | vCard
www.eversheds-sutherland.com

Eversheds Sutherland
Client Commitment. Innovative Solutions. Global Service.